TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Scanbio Ingredients AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
947,828
|
1,153,141
|
750,638 |
| Financial expenses |
283,490
|
257,360
|
110,951 |
| Earnings before taxes |
68,279
|
109,983
|
106,094 |
| Total assets |
932,556
|
695,795
|
537,612 |
| Current assets |
721,136
|
526,766
|
412,024 |
| Current liabilities |
584,192
|
325,904
|
185,144 |
| Equity capital |
342,730
|
365,362
|
351,772 |
| - share capital |
238,000
|
238,000
|
238,000 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
36.8%
|
52.5%
|
65.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
7.2%
|
9.5%
|
14.1% |
| Return on assets (ROA) |
37.7%
|
52.8%
|
40.4% |
| Current ratio |
123.4%
|
161.6%
|
222.5% |
| Return on equity (ROE) |
19.9%
|
30.1%
|
30.2% |
| Change turnover |
-205,313
|
402,503
|
127,905 |
| Change turnover % |
-18%
|
54%
|
21% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.